文献速递功能神经外科

下丘脑区域脑深部电刺激:一项系统综述

Deep brain stimulation of the hypothalamic region: a systematic review.
PubMed 文献 · Acta Neurochir (Wien) · 2025-02-04

该系统综述检索了PubMed、Scopus和Web of Science数据库,纳入34项研究共412例患者,评估下丘脑脑深部电刺激(DBS)的适应证与主要临床结果。最常见的适应证为难治性头痛(238例,57.8%),最常见靶点为下丘脑后部(30项研究,88.2%)。213例(51.7%)患者报告症状改善,25项(73.5%)研究报告了并发症。

要点

  • 下丘脑DBS最常见适应证为难治性头痛(238例,57.8%),其次为攻击行为(100例,24.3%)
  • 下丘脑后部是最常见靶点,30项研究(88.2%)涉及该靶点
  • 213例(51.7%)患者报告症状改善,改善幅度23.1%至100%

核心结论

  • 下丘脑DBS在多种难治性疾病(从头痛到攻击行为)的儿童和成人患者中是可行的。
  • 需要未来大规模、长期随访的研究来验证安全性和有效性数据并扩展这些发现。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索PubMed、Scopus和Web of Science数据库中关于人类下丘脑DBS的英文文献。
  • 初筛3148篇论文后,最终纳入34项研究、共412例患者,发表时间跨度为二十年。

主要发现

  • 适应证分布:难治性头痛238例(57.8%)、攻击行为100例(24.3%)、轻度阿尔茨海默病58例(14.1%)、多发性硬化相关三叉神经痛5例(1.2%)、Prader-Willi综合征4例(0.97%)、非典型面部疼痛3例(0.73%)。
  • 下丘脑后部是最常见靶点,涉及30项研究(88.2%)。
  • 262例(63.6%)为男性,110例(26.7%)为女性;303例(73.5%)为成人,33例(8.0%)为儿童。
  • 慢性难治性攻击行为患者的平均年龄最低,为15.25 ± 4.6岁;阿尔茨海默病患者的平均年龄最高,为68.5 ± 7.9岁。
  • 平均病程从2.2 ± 1.7年(轻度阿尔茨海默病)到19.8 ± 10.1年(难治性头痛)不等;213例(51.7%)患者来自29项研究(85.3%),报告症状改善幅度为23.1%至100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要未来大规模、长期随访的研究来验证安全性和有效性数据并扩展这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep brain stimulation (DBS) has been successfully used for the treatment of circuitopathies including movement, anxiety, and behavioral disorders. The hypothalamus is a crucial integration center for many peripheral and central pathways relating to cardiovascular, metabolic, and behavioral functions and constitutes a potential target for neuromodulation in treatment-refractory conditions. To conduct a systematic review, investigating hypothalamic targets in DBS, their indications, and the primary clinical findings. METHODS: PubMed, Scopus, and Web of Science databases were searched in accordance with the PRISMA guideline to identify papers published in English studying DBS of the hypothalamus in humans. RESULTS: After screening 3,148 papers, 34 studies consisting of 412 patients published over two decades were included in the final review. Hypothalamic DBS was indicated in refractory headaches (n = 238, 57.8%), aggressive behavior (n = 100, 24.3%), mild Alzheimer's disease (n = 58, 14.1%), trigeminal neuralgia in multiple sclerosis (n = 5, 1.2%), Prader-Willi syndrome (n = 4, 0.97%), and atypical facial pain (n = 3, 0.73%). The posterior hypothalamus was the most common DBS target site across 30 studies (88.2%). 262 (63.6%) participants were males, and 110 (26.7%) were females. 303 (73.5%) patients were adults whereas 33 (8.0%) were pediatrics. The lowest mean age of participants was 15.25 ± 4.6 years for chronic refractory aggressiveness, and the highest was 68.5 ± 7.9 years in Alzheimer's disease patients. The mean duration of the disease ranged from 2.2 ± 1.7 (mild Alzheimer's disease) to 19.8 ± 10.1 years (refractory headaches). 213 (51.7%) patients across 29 studies (85.3%) reported symptom improvements which ranged from 23.1% to 100%. 25 (73.5%) studies reported complications, most of which were associated with higher voltage stimulations. CONCLUSIONS: DBS of the hypothalamus is feasible in selected patients with various refractory conditions ranging from headaches to aggression in both pediatric and adult populations. Future large-scale studies with long-term follow-up are required to validate the safety and efficacy data and extend these findings.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Mofatteh M, Mohamed A, Mashayekhi MS, et al. Deep brain stimulation of the hypothalamic region: a systematic review. Acta Neurochir (Wien). 2025. PMID: 39904782. doi:10.1007/s00701-025-06430-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。